---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-074421"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2026-07-01T21:23:30+00:00"
generated_at: "2026-07-01T21:27:21.008977+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics raises $3M in private placement; warrants add up to $5.8M

## Summary
- Gross proceeds of $3M from sale of 960,000 pre-funded warrants at $3.1249/unit.
- Issued series C-1 and C-2 warrants to purchase up to 960,000 shares each at $3.00.
- Net proceeds to extend cash runway into Q1 2027; if warrants fully exercised, into H2 2027.
- H.C. Wainwright acted as exclusive placement agent; officers/directors subject to 60-day lock-up.
- Private placement closed July 1, 2026; securities unregistered, resale registration to be filed.

## SEC filing metadata
- accession: 0001213900-26-074421
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2026-07-01T21:23:30+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390026074421/0001213900-26-074421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390026074421/ea0296666-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-074421
- JSON: https://secwatch.observer/filing/0001213900-26-074421.json
- Plain text: https://secwatch.observer/filing/0001213900-26-074421.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.